Wells Fargo & Company MN Reduces Stock Position in Azenta, Inc. (NASDAQ:AZTA)

Wells Fargo & Company MN trimmed its holdings in Azenta, Inc. (NASDAQ:AZTA) by 6.3% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 221,145 shares of the company’s stock after selling 14,853 shares during the period. Wells Fargo & Company MN owned approximately 0.48% of Azenta worth $11,057,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. KLP Kapitalforvaltning AS purchased a new position in shares of Azenta in the fourth quarter valued at $530,000. State of Alaska Department of Revenue boosted its stake in Azenta by 355.2% in the 4th quarter. State of Alaska Department of Revenue now owns 25,899 shares of the company’s stock worth $1,294,000 after purchasing an additional 20,210 shares during the period. Stephens Inc. AR purchased a new position in Azenta during the 4th quarter valued at about $313,000. Thrivent Financial for Lutherans increased its position in shares of Azenta by 206.5% during the fourth quarter. Thrivent Financial for Lutherans now owns 35,223 shares of the company’s stock valued at $1,761,000 after buying an additional 23,731 shares during the period. Finally, SG Americas Securities LLC purchased a new stake in shares of Azenta in the fourth quarter worth about $813,000. Institutional investors own 99.08% of the company’s stock.

Azenta Stock Down 6.2 %

Shares of NASDAQ AZTA opened at $25.91 on Wednesday. The firm’s fifty day moving average is $38.34 and its 200 day moving average is $44.44. Azenta, Inc. has a 52 week low of $25.36 and a 52 week high of $63.58. The company has a market cap of $1.18 billion, a price-to-earnings ratio of -8.69 and a beta of 1.66.

Azenta (NASDAQ:AZTA) last released its quarterly earnings data on Wednesday, February 5th. The company reported $0.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.05 by $0.03. Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. Equities research analysts anticipate that Azenta, Inc. will post 0.53 earnings per share for the current year.

Analyst Ratings Changes

Several equities analysts recently commented on AZTA shares. Needham & Company LLC upped their target price on shares of Azenta from $55.00 to $59.00 and gave the stock a “buy” rating in a report on Thursday, February 6th. Evercore ISI upped their price target on shares of Azenta from $50.00 to $52.00 and gave the stock an “in-line” rating in a report on Thursday, February 6th. Stephens reiterated an “overweight” rating and issued a $60.00 price objective on shares of Azenta in a research report on Thursday, January 2nd. Finally, TD Cowen upgraded Azenta to a “hold” rating in a research report on Thursday, February 27th.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.